Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-26 Sale |
2023-06-28 3:47 pm |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
16 | $12.93 | $207 | 3,848,632 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 5:15 pm |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
2,056 | $12.14 | $24,960 | 3,848,648 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 6:33 pm |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
5,893 | $12.29 | $72,412 | 3,850,704 (Direct) |
View |
| 2022-11-17 Purchase |
2022-11-21 6:26 pm |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
400,000 | $12.5 | $5,000,000 | 3,856,597 (Direct) |
View |
| 2022-11-17 Purchase |
2022-11-21 4:31 pm |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
3,389,500 | $12.5 | $42,368,750 | 426,302 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-14 Tax Withholding |
2024-02-16 5:12 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
434 | $3.4 | 27,626 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:10 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer |
468 | $3.4 | 18,167 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:08 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
723 | $3.4 | 59,710 (Direct) |
View |
| 2024-02-14 Tax Withholding |
2024-02-16 5:06 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
41,861 | $3.4 | 2,935,038 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 4:37 pm |
N/A 2034-02-07 |
Acrivon Therapeutics Inc. | ACRV | Magovcevic-Liebisch Ivana Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-01-17 Tax Withholding |
2024-01-19 4:24 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
652 | $4.35 | 40,668 (Direct) |
View |
| 2024-01-11 Option Award |
2024-01-16 4:45 pm |
N/A 2034-01-10 |
Acrivon Therapeutics Inc. | ACRV | Cuillerot Jean-Marie Chief Medical Officer |
99,300 | $0 | 99,300 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:43 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
735 | $5.08 | 41,320 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:42 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
1,900 | $5.08 | 2,977,478 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:42 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
1,470 | $5.08 | 28,060 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer |
1,395 | $5.08 | 18,635 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
2,450 | $5.08 | 60,433 (Direct) |
View |
| 2023-11-14 Tax Withholding |
2023-11-16 7:41 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
239,023 | $5.08 | 2,977,478 (Direct) |
View |
| 2023-10-17 Tax Withholding |
2023-10-19 7:45 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
2,232 | $5.48 | 42,055 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 7:17 pm |
N/A 2033-09-25 |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
15,434 | $0 | 55,863 (Direct) |
View |
Ownership |
2023-09-28 7:13 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Miller Mary Chief Legal Officer |
0 | $0 | 161,715 (Direct) |
View |
| 2023-08-21 Option Award |
2023-08-23 4:19 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
493,994 | $0 | 3,218,401 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-28 5:06 pm |
N/A 2033-06-21 |
Acrivon Therapeutics Inc. | ACRV | BAUM CHARLES M Director |
32,500 | $0 | 32,500 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-20 5:21 pm |
N/A 2032-06-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
9,500 | $0 | 212,649 (Direct) |
View |
| 2023-06-16 Exercise |
2023-06-20 5:21 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
9,500 | $3.63 | 212,649 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-06 4:15 pm |
N/A 2031-01-13 |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
9,225 | $0 | 159,498 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-06 4:15 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
9,225 | $1.04 | 159,498 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 8:40 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
33,605 | $3.88 | 2,877,492 (Direct) |
View |
| 2023-05-31 Exercise |
2023-06-01 8:40 pm |
N/A 2032-03-22 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
33,605 | $0 | 2,877,492 (Direct) |
View |
| 2022-11-17 Conversion |
2022-11-21 6:26 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
11,980,570 | $0 | 3,856,597 (Direct) |
View |
| 2022-11-17 Conversion |
2022-11-21 4:31 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
4,925,218 | $0 | 426,302 (Indirect) |
View |
| 2022-11-17 Conversion |
2022-11-21 1:22 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
3,078,261 | $0 | 888,130 (Direct) |
View |
Ownership |
2022-11-18 4:34 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
0 | $0 | 3,007,858 (Indirect) |
View |
| 2022-11-14 Option Award |
2022-11-16 9:05 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | DiRocco Derek Director |
35,235 | $0 | 35,235 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:33 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
35,235 | $0 | 35,235 (Indirect) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:28 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director |
35,235 | $0 | 35,235 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:25 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director |
35,235 | $0 | 35,235 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:21 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer |
80,120 | $0 | 80,120 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:18 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
133,533 | $0 | 153,808 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:13 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
80,120 | $0 | 80,120 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:10 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
1,785,336 | $0 | 2,951,191 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:05 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
1,785,336 | $0 | 2,951,191 (Direct) |
View |